Active salvage chemotherapy versus best supportive care for patients with recurrent or metastatic squamous cell carcinoma of the esophagus refractory or intolerable to fluorouracil, platinum, and taxane

被引：0
|
作者：
Motoo Nomura
Satoru Iwasa
Takahiro Tsushima
Ken Kato
Hirofumi Yasui
Narikazu Boku
Manabu Muto
Kei Muro
机构：
[1] Aichi Cancer Center Hospital,Department of Clinical Oncology
[2] Kyoto University Graduate School of Medicine,Department of Therapeutic Oncology
[3] National Cancer Center Hospital,Division of Gastrointestinal Medical Oncology
[4] Shizuoka Cancer Center,Division of Gastrointestinal Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 78卷
关键词：
Esophageal cancer; Metastasis; Best supportive care; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1209 / 1216
页数：7
相关论文
共 50 条
  • [1] Active salvage chemotherapy versus best supportive care for patients with recurrent or metastatic squamous cell carcinoma of the esophagus refractory or intolerable to fluorouracil, platinum, and taxane
    Nomura, Motoo
    Iwasa, Satoru
    Tsushima, Takahiro
    Kato, Ken
    Yasui, Hirofumi
    Boku, Narikazu
    Muto, Manabu
    Muro, Kei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (06) : 1209 - 1216
  • [2] Salvage chemotherapy versus best supportive care in patients with recurrent or metastatic squamous cell carcinoma of the esophagus refractory or intolerable to fluorouracil, platinum, and taxane.
    Tsushima, Takahiro
    Nomura, Motoo
    Iwasa, Satoru
    Kato, Ken
    Yasui, Hirofumi
    Muro, Kei
    Boku, Narikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum
    Kentaro Yamazaki
    Shuichi Hironaka
    Narikazu Boku
    Hirofumi Yasui
    Akira Fukutomi
    Takayuki Yoshino
    Yusuke Onozawa
    Noriaki Hasuike
    Tetsuya Inui
    Yuichiro Yamaguchi
    Hiroyuki Ono
    International Journal of Clinical Oncology, 2008, 13 : 150 - 155
  • [4] A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum
    Yamazaki, Kentaro
    Hironaka, Shuichi
    Boku, Narikazu
    Yasui, Hirofumi
    Fukutomi, Akira
    Yoshino, Takayuki
    Onozawa, Yusuke
    Hasuike, Noriaki
    Inui, Tetsuya
    Yamaguchi, Yuichiro
    Ono, Hiroyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (02) : 150 - 155
  • [5] Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial
    Machiels, Jean-Pascal
    Subramanian, Somasundaram
    Ruzsa, Agnes
    Repassy, Gabor
    Lifirenko, Igor
    Flygare, Annika
    Sorensen, Per
    Nielsen, Tina
    Lisby, Steen
    Clement, Paul M. J.
    LANCET ONCOLOGY, 2011, 12 (04): : 333 - 343
  • [6] Second-line combination chemotherapy with docetaxel and nedaplatin for metastatic or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus cisplatin
    Kawabata, Ryohei
    Imamura, Hiroshi
    Kishimoto, Tomono
    Kitamura, Shinji
    Hachino, Yoshimi
    Yasui, Yukako
    Fujino, Misako
    Fujii, Chika
    Furukawa, Hiroshi
    ESOPHAGUS, 2011, 8 (03) : 179 - 185
  • [7] Second-line combination chemotherapy with docetaxel and nedaplatin for metastatic or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus cisplatin
    Ryohei Kawabata
    Hiroshi Imamura
    Tomono Kishimoto
    Shinji Kitamura
    Yoshimi Hachino
    Yukako Yasui
    Misako Fujino
    Chika Fujii
    Hiroshi Furukawa
    Esophagus, 2011, 8 : 179 - 185
  • [8] A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy
    León, X
    Hitt, R
    Constenla, M
    Rocca, A
    Stupp, R
    Kovács, AF
    Amellal, N
    Bessa, EH
    Bourhis, J
    CLINICAL ONCOLOGY, 2005, 17 (06) : 418 - 424
  • [9] Salvage combination chemotherapy with irinotecan 5-fluorouracil and leucovorin for taxane- and platinum-refractory, metastatic gastric cancer
    Kim, Seung Tai
    Kang, Won Ki
    Song, Seo-Young
    Lee, Soon Il
    Nam, Eunmi
    Kim, Jung Han
    Park, Gun Woo
    Park, Joon Oh
    Park, Young Suk
    Park, Keunchil
    ANNALS OF ONCOLOGY, 2004, 15 : 234 - 235
  • [10] Platinum/taxane/pembrolizumab vs Platinum/5-fluorouracil/pembrolizumab in recurrent/metastatic Head and Neck Squamous Cell Carcinoma (r/m HNSCC)
    Sun, L.
    Cohen, R.
    Colevas, A. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E34 - E35
12345